The Pharmaceutical Excipients Market Size accounted for USD 9.3 Billion in 2023 and is estimated to achieve a market size of USD 17.2 Billion by 2032 growing at a CAGR of 7.2% from 2024 to 2032.
Pharmaceutical Excipients Market Highlights
- Global pharmaceutical excipients market revenue is poised to garner USD 17.2 billion by 2032 with a CAGR of 7.2% from 2024 to 2032
- North America pharmaceutical excipients market value occupied around USD 3.6 billion in 2023
- Asia-Pacific pharmaceutical excipients market growth will record a CAGR of more than 8% from 2024 to 2032
- Among function, the binders sub-segment generated more than USD 1.7 billion revenue in 2023
- Based on formulation, the oral sub-segment generated around 41% pharmaceutical excipients market share in 2023
- Advancements in nanotechnology and drug delivery technologies is a popular pharmaceutical excipients market trend that fuels the industry demand
Pharmaceutical excipients are pharmaceutically inactive substances in the final formulation. Standard purposes of using excipients along with the active ingredients are streamlining the manufacturing of formulation and facilitate physiological absorption of drugs and support or enhance the stability of formulation. Various excipients are used in the single formulation and account for about 90% of the product. However, they cost about 0.5% to 1.0% of the total product. Emerging multifunctional excipients, growing pharmaceutical industry, and surge in the demand of generics are the key growth factors of the market.
Flavoring agents & sweeteners and coloring agents are used to enhance the aesthetic nature of formulation and improve the ease of administration among patients. Fillers and diluents accounted for the largest share of the market as they are used to provide bulk to the formulation. Hence, the requirement of fillers is more in the final formulation. Organic chemicals and inorganic chemicals are the key pharmaceutical excipients.
Global Pharmaceutical Excipients Market Dynamics
Market Drivers
- Rising prevalence of chronic diseases
- Multifunctional excipients are becoming increasingly popular
- Pharmaceutical production is becoming more prevalent in emerging markets
Market Restraints
- Stringent regulatory standards
- Production costs are high in developed regions
- Disruptions in the supply chain impair raw material availability
Market Opportunities
- Growth in developing markets such as Asia Pacific and Latin America
- Excipients that are both novel and sustainable will be developed
- Biologics and specialized pharmaceuticals have seen increased investment
Pharmaceutical Excipients Market Report Coverage
| Market |
Pharmaceutical Excipients Market
|
| Pharmaceutical Excipients Market Size 2022 |
USD 9.3 Billion |
| Pharmaceutical Excipients Market Forecast 2032 |
USD 17.2 Billion |
| Pharmaceutical Excipients Market CAGR During 2023 - 2032 |
7.2% |
| Pharmaceutical Excipients Market Analysis Period |
2020 - 2032 |
Pharmaceutical Excipients Market Base Year
|
2022 |
| Pharmaceutical Excipients Market Forecast Data |
2023 - 2032 |
| Segments Covered |
By Product, By Function, By Formulation, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Kerry Group, Lubrizol Corporation, DuPont, Associated British Foods, BASF SE, Croda International, Roquette Frères, Evonik Industries AG, Ashland Global Holdings, and Archer Daniels Midland Company.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Pharmaceutical Excipients Market Insights
Several factors drive the pharmaceutical excipients market, including the expansion of the pharmaceutical industry, the rising usage of multifunctional excipients, and the availability of high-quality raw materials and excipients. Rising drug demand, particularly in response to the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular problems, is propelling the pharmaceutical business forward. As the demand for effective and efficient drug delivery systems rises, so does the need for multifunctional excipients that improve the performance of active pharmaceutical ingredients. Furthermore, the availability of high-quality raw materials and excipients ensures that pharmaceutical products are consistently manufactured.
Furthermore, the entry of pharmaceutical behemoths into emerging countries such as Asia-Pacific and Latin America is a major driver of market growth. These regions are experiencing a growth in disposable income and healthcare awareness, which is increasing demand for pharmaceutical products and, consequently, excipients. Pharmaceutical use is growing over the world as a result of enhanced healthcare infrastructure, advantageous reimbursement schemes, and technological advancements. Telehealth facilities also play an important role in providing healthcare services and expert consultations to rural and isolated areas, hence improving pharmaceutical availability. However, market expansion is limited by high production costs in industrialized countries and severe regulatory controls. These issues present obstacles to manufacturers, potentially limiting the overall growth of the pharmaceutical excipients market.
Pharmaceutical Excipients Market Segmentation
The worldwide market for pharmaceutical excipients is split based on product, function, formulation, and geography.
Pharmaceutical Excipients Market By Product
- Organic Chemicals
- Oleochemicals
- Carbohydrates
- Petrochemicals
- Proteins
- Others
- Inorganic Chemicals
- Calcium Phosphate
- Metal Oxides
- Halites
- Calcium Carbonate
- Calcium Sulphate
- Others
- Others
According to pharmaceutical excipients industry analysis, based on the product, the pharmaceutical excipients are divided into organic chemicals, inorganic chemicals, and others. The organic chemicals segment dominated the pharmaceutical excipients market in 2023. This can be attributed to high demand from the pharmaceutical industry as organic chemicals such as proteins, carbohydrates, oleochemicals, and petrochemicals are majorly used in pharmaceutical formulations.
Pharmaceutical Excipients Market By Functions
- Coating Agents
- Fillers & Diluents
- Suspending & Viscosity Agents
- Binders
- Flavoring Agents & Sweeteners
- Disintegrants
- Colorants
- Emulsifying agents
- Lubricants & Glidants
- Preservatives
- Others
On the basis of function, the market has been segmented into coating agents, filers & diluents, suspending & viscosity agents, binders, flavoring agents & sweeteners, disintegrants, colorants, emulsifying agents, lubricants & glidants, and preservatives. Binders sub segment is the generate largest revenue in the market and the fillers & diluents segment has the notable share. These excipients are important in tablet and capsule formulations because they help produce the proper size and shape, making the product easier to handle and administer. Fillers and diluents also play an important role in ensuring appropriate dose of active pharmaceutical ingredients (APIs) by adding bulk. Their widespread use in a variety of dosage forms, as well as the increased production of solid oral pharmaceuticals, contribute to their market domination, making them an essential component in pharmaceutical manufacturing.
Pharmaceutical Excipients Market By Formulations
- Oral
- Tablet
- Capsule
- Hard gelatin
- Soft gelatin
- Other oral formulations
- Liquid
- Parenteral
- Topical
- Other formulations
The oral formulation sector is estimated to account for a sizable percentage in the pharmaceutical excipients market forecast period due to rising demand for oral drug delivery methods such as tablets, capsules, and liquids. Oral formulations are favored for their ease of usage, patient compliance, and cost effectiveness. They are also adaptable, supporting controlled-release, immediate-release, and sustained-release characteristics. The rising prevalence of chronic diseases, as well as the growing demand for generic pharmaceuticals, drive up the manufacturing of oral dosage forms. As a result, the demand for excipients in these formulations is likely to stay high, boosting market growth.
Pharmaceutical Excipients Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Pharmaceutical Excipients Market Regional Analysis
North America dominated the market in 2023. However, Asia-Pacific is anticipated to propel the market growth with the fastest rate during the pharmaceutical excipient industry forecast period. Presence of pharmaceutical giants in the region, emphasis on high quality pharmaceutical products, and high consumption & demand for novel excipients are the key driving factors for the dominance of North America in the global market. The increasing number of pharmaceutical product manufacturers in Asia Pacific is expected to increase the demand for excipients in the coming years. Furthermore, extensive R&D in healthcare, rising disposable income, and increasing treatment rate are other factors to boost the pharmaceutical excipients market in Asia Pacific. Low cost raw materials and workforce and availability of resources for manufacturing facility are attracting several pharmaceutical companies in Asia Pacific. Japan, China, India, Singapore, and Australia are some of the major contributing countries in the region.
Pharmaceutical Excipients Market Players
Some of the top pharmaceutical excipients companies offered in our report includes Kerry Group, Lubrizol Corporation, DuPont, Associated British Foods, BASF SE, Croda International, Roquette Frères, Evonik Industries AG, Ashland Global Holdings, and Archer Daniels Midland Company.
CHAPTER 1. Industry Overview of Pharmaceutical Excipients Market
1.1. Definition and Scope
1.1.1. Definition of Pharmaceutical Excipients
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Pharmaceutical Excipients Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Pharmaceutical Excipients Market By Product
1.2.3. Pharmaceutical Excipients Market By Function
1.2.4. Pharmaceutical Excipients Market By Formulation
1.2.5. Pharmaceutical Excipients Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Pharmaceutical Excipients Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Pharmaceutical Excipients Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Pharmaceutical Excipients Market By Product
5.1. Introduction
5.2. Pharmaceutical Excipients Revenue By Product
5.2.1. Pharmaceutical Excipients Revenue (USD Million) and Forecast, By Product, 2020-2032
5.2.2. Organic Chemicals
5.2.2.1. Organic Chemicals Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.2. Oleochemicals
5.2.2.2.1. Oleochemicals Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.3. Carbohydrates
5.2.2.3.1. Carbohydrates Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.4. Petrochemicals
5.2.2.4.1. Petrochemicals Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.5. Proteins
5.2.2.5.1. Proteins Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.6. Others
5.2.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Inorganic Chemicals
5.2.3.1. Inorganic Chemicals Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.2. Calcium Phosphate
5.2.3.2.1. Calcium Phosphate Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.3. Metal Oxides
5.2.3.3.1. Metal Oxides Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.4. Halites
5.2.3.4.1. Halites Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.5. Calcium Carbonate
5.2.3.5.1. Calcium Carbonate Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.6. Calcium Sulphate
5.2.3.6.1. Calcium Sulphate Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.7. Others
5.2.3.7.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Others
5.2.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Pharmaceutical Excipients Market By Function
6.1. Introduction
6.2. Pharmaceutical Excipients Revenue By Function
6.2.1. Pharmaceutical Excipients Revenue (USD Million) and Forecast, By Function, 2020-2032
6.2.2. Coating Agents
6.2.2.1. Coating Agents Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Fillers & Diluents
6.2.3.1. Fillers & Diluents Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Suspending & Viscosity Agents
6.2.4.1. Suspending & Viscosity Agents Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.5. Binders
6.2.5.1. Binders Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.6. Flavoring Agents & Sweeteners
6.2.6.1. Flavoring Agents & Sweeteners Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.7. Disintegrants
6.2.7.1. Disintegrants Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.8. Colorants
6.2.8.1. Colorants Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.9. Emulsifying agents
6.2.9.1. Emulsifying agents Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.10. Lubricants & Glidants
6.2.10.1. Lubricants & Glidants Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.11. Preservatives
6.2.11.1. Preservatives Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.12. Others
6.2.12.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Pharmaceutical Excipients Market By Formulation
7.1. Introduction
7.2. Pharmaceutical Excipients Revenue By Formulation
7.2.1. Pharmaceutical Excipients Revenue (USD Million) and Forecast, By Formulation, 2020-2032
7.2.2. Oral
7.2.2.1. Oral Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Tablet
7.2.3.1. Tablet Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Capsule
7.2.4.1. Capsule Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4.2. Hard gelatin
7.2.4.2.1. Hard gelatin Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4.3. Soft gelatin
7.2.4.3.1. Soft gelatin Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4.4. Other oral formulations
7.2.4.4.1. Other oral formulations Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.5. Liquid
7.2.5.1. Liquid Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.6. Parenteral
7.2.6.1. Parenteral Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.7. Topical
7.2.7.1. Topical Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.8. Others formulations
7.2.8.1. Others formulations Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Pharmaceutical Excipients Market By Country
8.1. North America Pharmaceutical Excipients Market Overview
8.2. U.S.
8.2.1. U.S. Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
8.2.2. U.S. Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
8.2.3. U.S. Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
8.3. Canada
8.3.1. Canada Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
8.3.2. Canada Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
8.3.3. Canada Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Pharmaceutical Excipients Market By Country
9.1. Europe Pharmaceutical Excipients Market Overview
9.2. U.K.
9.2.1. U.K. Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
9.2.2. U.K. Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
9.2.3. U.K. Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
9.3. Germany
9.3.1. Germany Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
9.3.2. Germany Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
9.3.3. Germany Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
9.4. France
9.4.1. France Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
9.4.2. France Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
9.4.3. France Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
9.5. Spain
9.5.1. Spain Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
9.5.2. Spain Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
9.5.3. Spain Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
9.6.2. Rest of Europe Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
9.6.3. Rest of Europe Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Pharmaceutical Excipients Market By Country
10.1. Asia Pacific Pharmaceutical Excipients Market Overview
10.2. China
10.2.1. China Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
10.2.2. China Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
10.2.3. China Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
10.3. Japan
10.3.1. Japan Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
10.3.2. Japan Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
10.3.3. Japan Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
10.4. India
10.4.1. India Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
10.4.2. India Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
10.4.3. India Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
10.5. Australia
10.5.1. Australia Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
10.5.2. Australia Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
10.5.3. Australia Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
10.6. South Korea
10.6.1. South Korea Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
10.6.2. South Korea Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
10.6.3. South Korea Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
10.7.2. Rest of Asia-Pacific Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
10.7.3. Rest of Asia-Pacific Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Pharmaceutical Excipients Market By Country
11.1. Latin America Pharmaceutical Excipients Market Overview
11.2. Brazil
11.2.1. Brazil Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
11.2.2. Brazil Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
11.2.3. Brazil Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
11.3. Mexico
11.3.1. Mexico Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
11.3.2. Mexico Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
11.3.3. Mexico Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
11.4.2. Rest of Latin America Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
11.4.3. Rest of Latin America Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Pharmaceutical Excipients Market By Country
12.1. Middle East & Africa Pharmaceutical Excipients Market Overview
12.2. GCC
12.2.1. GCC Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
12.2.2. GCC Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
12.2.3. GCC Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
12.3. South Africa
12.3.1. South Africa Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
12.3.2. South Africa Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
12.3.3. South Africa Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Pharmaceutical Excipients Revenue (USD Million) and Forecast By Product, 2020-2032
12.4.2. Rest of Middle East & Africa Pharmaceutical Excipients Revenue (USD Million) and Forecast By Function, 2020-2032
12.4.3. Rest of Middle East & Africa Pharmaceutical Excipients Revenue (USD Million) and Forecast By Formulation, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Pharmaceutical Excipients Market
13.1. Pharmaceutical Excipients Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Pharmaceutical Excipients Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Kerry Group
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Million), 2023
14.1.3.2. Kerry Group 2023 Pharmaceutical Excipients Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Lubrizol Corporation
14.3. DuPont
14.4. Associated British Foods
14.5. BASF SE
14.6. Croda International
14.7. Roquette Frères
14.8. Evonik Industries AG
14.9. Ashland Global Holdings
14.10. Archer Daniels Midland Company
